U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from PMC

Chronic obstructive pulmonary disease(COPD)

MedGen UID:
9818
Concept ID:
C0024117
Disease or Syndrome
Synonym: Chronic pulmonary obstruction
SNOMED CT: Chronic obstructive lung disease (13645005); Chronic airway obstruction (13645005); Chronic irreversible airway obstruction (13645005); CAFL - Chronic airflow limitation (13645005); COAD - Chronic obstructive airways disease (13645005); Chronic airflow limitation (13645005); CAL - Chronic airflow limitation (13645005); COPD - Chronic obstructive pulmonary disease (13645005); Chronic obstructive airway disease (13645005); Chronic airway disease (13645005); COLD - Chronic obstructive lung disease (13645005); Chronic obstructive pulmonary disease (13645005)
 
Related genes: SCNN1G, SCNN1B, SCNN1A, MMP1, HMOX1, CFTR
 
HPO: HP:0006510
Monarch Initiative: MONDO:0005002
OMIM®: 606963

Definition

Chronic obstructive pulmonary disease (COPD) is a common, complex disorder associated with substantial morbidity and mortality. COPD is defined by irreversible airflow obstruction due to chronic bronchitis, emphysema, and/or small airways disease. Airflow obstruction is typically determined by reductions in quantitative spirometric indices, including forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) (Silverman et al., 2002; Celedon et al., 2004). [from OMIM]

Conditions with this feature

DiGeorge syndrome
MedGen UID:
4297
Concept ID:
C0012236
Disease or Syndrome
Individuals with 22q11.2 deletion syndrome (22q11.2DS) can present with a wide range of features that are highly variable, even within families. The major clinical manifestations of 22q11.2DS include congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus), palatal abnormalities (velopharyngeal incompetence, submucosal cleft palate, bifid uvula, and cleft palate), immune deficiency, characteristic facial features, and learning difficulties. Hearing loss can be sensorineural and/or conductive. Laryngotracheoesophageal, gastrointestinal, ophthalmologic, central nervous system, skeletal, and genitourinary anomalies also occur. Psychiatric illness and autoimmune disorders are more common in individuals with 22q11.2DS.
Alpha-1-antitrypsin deficiency
MedGen UID:
67461
Concept ID:
C0221757
Disease or Syndrome
Alpha-1 antitrypsin deficiency (AATD) can present with hepatic dysfunction in individuals from infancy to adulthood and with chronic obstructive lung disease (emphysema and/or bronchiectasis), characteristically in individuals older than age 30 years. Individuals with AATD are also at increased risk for panniculitis (migratory, inflammatory, tender skin nodules which may ulcerate on legs and lower abdomen) and C-ANCA-positive vasculitis (granulomatosis with polyangiitis). Phenotypic expression varies within and between families. In adults, smoking is the major factor in accelerating the development of COPD; nonsmokers may have a normal life span, but can also develop lung and/or liver disease. Although reported, emphysema in children with AATD is extremely rare. AATD-associated liver disease, which is present in only a small portion of affected children, manifests as neonatal cholestasis. The incidence of liver disease increases with age. Liver disease in adults (manifesting as cirrhosis and fibrosis) may occur in the absence of a history of neonatal or childhood liver disease. The risk for hepatocellular carcinoma (HCC) is increased in individuals with AATD.
COPD, severe early onset
MedGen UID:
376022
Concept ID:
C1847014
Disease or Syndrome
Emphysema, hereditary pulmonary
MedGen UID:
338765
Concept ID:
C1851718
Disease or Syndrome
Primary ciliary dyskinesia 12
MedGen UID:
436379
Concept ID:
C2675228
Disease or Syndrome
Primary ciliary dyskinesia is a disorder characterized by chronic respiratory tract infections, abnormally positioned internal organs, and the inability to have children (infertility). The signs and symptoms of this condition are caused by abnormal cilia and flagella. Cilia are microscopic, finger-like projections that stick out from the surface of cells. They are found in the linings of the airway, the reproductive system, and other organs and tissues. Flagella are tail-like structures, similar to cilia, that propel sperm cells forward.\n\nIn the respiratory tract, cilia move back and forth in a coordinated way to move mucus towards the throat. This movement of mucus helps to eliminate fluid, bacteria, and particles from the lungs. Most babies with primary ciliary dyskinesia experience breathing problems at birth, which suggests that cilia play an important role in clearing fetal fluid from the lungs. Beginning in early childhood, affected individuals develop frequent respiratory tract infections. Without properly functioning cilia in the airway, bacteria remain in the respiratory tract and cause infection. People with primary ciliary dyskinesia also have year-round nasal congestion and a chronic cough. Chronic respiratory tract infections can result in a condition called bronchiectasis, which damages the passages, called bronchi, leading from the windpipe to the lungs and can cause life-threatening breathing problems.\n\nApproximately 12 percent of people with primary ciliary dyskinesia have a condition known as heterotaxy syndrome or situs ambiguus, which is characterized by abnormalities of the heart, liver, intestines, or spleen. These organs may be structurally abnormal or improperly positioned. In addition, affected individuals may lack a spleen (asplenia) or have multiple spleens (polysplenia). Heterotaxy syndrome results from problems establishing the left and right sides of the body during embryonic development. The severity of heterotaxy varies widely among affected individuals.\n\nSome individuals with primary ciliary dyskinesia have abnormally placed organs within their chest and abdomen. These abnormalities arise early in embryonic development when the differences between the left and right sides of the body are established. About 50 percent of people with primary ciliary dyskinesia have a mirror-image reversal of their internal organs (situs inversus totalis). For example, in these individuals the heart is on the right side of the body instead of on the left. Situs inversus totalis does not cause any apparent health problems. When someone with primary ciliary dyskinesia has situs inversus totalis, they are often said to have Kartagener syndrome.\n\nPrimary ciliary dyskinesia can also lead to infertility. Vigorous movements of the flagella are necessary to propel the sperm cells forward to the female egg cell. Because their sperm do not move properly, males with primary ciliary dyskinesia are usually unable to father children. Infertility occurs in some affected females and is likely due to abnormal cilia in the fallopian tubes.\n\nAnother feature of primary ciliary dyskinesia is recurrent ear infections (otitis media), especially in young children. Otitis media can lead to permanent hearing loss if untreated. The ear infections are likely related to abnormal cilia within the inner ear.\n\nRarely, individuals with primary ciliary dyskinesia have an accumulation of fluid in the brain (hydrocephalus), likely due to abnormal cilia in the brain.
Primary ciliary dyskinesia 24
MedGen UID:
815964
Concept ID:
C3809634
Disease or Syndrome
Primary ciliary dyskinesia-24 is an autosomal recessive disorder resulting from defects of motile cilia. It is characterized clinically by sinopulmonary infection and subfertility; situs inversus is not observed. Ultrastructural examination of mutant cilia shows defects of the central microtubule complex and radial spokes (summary by Kott et al., 2013). For a phenotypic description and a discussion of genetic heterogeneity of primary ciliary dyskinesia, see 244400.
Primary ciliary dyskinesia 25
MedGen UID:
815971
Concept ID:
C3809641
Disease or Syndrome
Primary ciliary dyskinesia-25 is an autosomal recessive disorder caused by defective ciliary movement. Affected individuals have recurrent upper and lower airway disease, bronchiectasis, and decreased fertility. About half of patients show laterality defects, including situs inversus totalis. Respiratory cilia from patients show defects in the inner and outer dynein arms (summary by Tarkar et al., 2013). For a general phenotypic description and a discussion of genetic heterogeneity of primary ciliary dyskinesia, see 244400.
Immunodeficiency, common variable, 12
MedGen UID:
906018
Concept ID:
C4225277
Disease or Syndrome
Common variable immunodeficiency-12 with autoimmunity (CVID12) is an autosomal dominant complex immunologic disorder with multisystem involvement. CVID12 is mainly a primary immunodeficiency characterized by recurrent infections and associated with hypogammaglobulinemia. Notably, about half of patients develop autoimmune features, including cytopenia, as well as generalized inflammation and lymphoproliferation manifest as lymphadenopathy or hepatosplenomegaly. A smaller percentage of affected individuals (less than 20%) develop cancer, most commonly solid tumors, including lymphoma. Age at onset and disease severity are highly variable, even within the same family. There is also incomplete penetrance, such that mutation carriers may be asymptomatic, even if they have hypogammaglobulinemia. The gene involved, NFKB1, encodes a transcription factor that regulates the expression of target genes involved in the immune system, thus defining the phenotype as a disorder of immune dysregulation (summary by Fliegauf et al., 2015; Lorenzini et al., 2020). For a general description and a discussion of genetic heterogeneity of common variable immunodeficiency, see CVID1 (607594).
Primary ciliary dyskinesia 32
MedGen UID:
896106
Concept ID:
C4225311
Disease or Syndrome
Primary ciliary dyskinesia-32 is an autosomal recessive disorder caused by defective structure and function of cilia. Ciliary dysfunction causes respiratory distress in term neonates, impaired mucociliary clearance, chronic respiratory infections, bronchiectasis, and infertility. The ciliary defect affects the central pair complex and radial spokes of the 9+2 motile cilia; affected individuals do not have situs abnormalities (summary by Jeanson et al., 2015). For a general phenotypic description and a discussion of genetic heterogeneity of primary ciliary dyskinesia, see CILD1 (244400).
Severe combined immunodeficiency due to CARMIL2 deficiency
MedGen UID:
1648422
Concept ID:
C4748304
Disease or Syndrome
Immunodeficiency-58 is an autosomal recessive primary immunologic disorder characterized by early-onset skin lesions, including eczematous dermatitis, infectious abscesses, and warts, recurrent respiratory infections or allergies, and chronic persistent infections with candida, Molluscum contagiosum, mycobacteria, EBV, bacteria, and viruses. Some patients may have gastrointestinal involvement, including inflammatory bowel disease, EBV+ smooth muscle tumors, and esophagitis. Immunologic analysis shows defective T-cell function with decreased Treg cells and deficient CD3/CD28 costimulation responses in both CD4+ and CD8+ T cells. B-cell function may also be impaired (summary by Wang et al., 2016 and Alazami et al., 2018).
Ciliary dyskinesia, primary, 42
MedGen UID:
1684665
Concept ID:
C5231464
Disease or Syndrome
Primary ciliary dyskinesia-42 (CILD42) is an autosomal recessive disorder characterized by a defect in motile cilia and ciliary clearance resulting in the onset of respiratory insufficiency soon after birth, and associated with recurrent upper and lower respiratory infections with chronic progressive lung disease. Other more variable features may include infertility and mild hydrocephalus. Patients with this form of the disorder do not have situs abnormalities. The disorder is considered to be a type of ciliopathy known as 'reduced generation of multiple motile cilia' (RGMC) (summary by Boon et al., 2014). For a discussion of genetic heterogeneity of primary ciliary dyskinesia, CILD1 (244400).
Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia
MedGen UID:
1740566
Concept ID:
C5436549
Disease or Syndrome
Immunodeficiency-73B with defective neutrophil chemotaxis (IMD73B) is an autosomal dominant immunologic disorder characterized by onset of recurrent infections in infancy or early childhood. Affected individuals develop respiratory infections, cellulitis, and severe invasive infections or sepsis; organisms include bacteria such as Staphylococcus, as well as viruses, fungi, and mycobacterial species. Laboratory studies show variable abnormalities, including B- and T-cell lymphopenia, decreased immunoglobulin subsets, decreased TRECs and dysfunctional T cells, decreased NK cells, neutropenia, and impaired neutrophil chemotaxis. Hematopoietic stem cell transplantation is curative (summary by Hsu et al., 2019; review by Lougaris et al., 2020). In a review of autosomal forms of chronic granulomatous disease (see 306400 for genetic heterogeneity of CGD), Roos et al. (2021) noted that patients with RAC2 mutations may manifest CGD-like symptoms due to defects in neutrophil NADPH oxidase activity.
Immunodeficiency 77
MedGen UID:
1788976
Concept ID:
C5543173
Disease or Syndrome
Immunodeficiency-77 (IMD77) is an immunologic disorder characterized by recurrent and persistent polymicrobial infections with multiple unusual organisms. Skin and pulmonary infections are the most common, consistent with increased susceptibility to epithelial cell infections. The age at onset is highly variable: some patients have recurrent infections from childhood, whereas others present in late adulthood. The limited number of reported patients are all female, suggesting incomplete penetrance or a possible sex-influenced trait. Patient cells, mainly macrophages, show impaired killing of intracellular bacteria and organisms, including nontubercular mycobacteria, although there is also impaired killing of other organisms, such as Pseudomonas, Candida, and Aspergillus. Treatment with gamma-IFN (IFNG; 147570) may be a therapeutic option (summary by McCormack et al., 2017 and Merselis et al., 2020).
Aortic aneurysm, familial thoracic 12
MedGen UID:
1802657
Concept ID:
C5676959
Disease or Syndrome
Familial thoracic aortic aneurysm-12 (AAT12) is characterized by dilation of the arterial wall associated with a progressive loss of its ability to withstand the wall tension generated by high intraluminal pressure, which can lead to intramural or complete acute vessel wall rupture. Some patients have dolichostenomelia (summary by Elbitar et al., 2021). For a general phenotypic description and a discussion of genetic heterogeneity of thoracic aortic aneurysm, see AAT1 (607086).

Professional guidelines

PubMed

Kahnert K, Jörres RA, Behr J, Welte T
Dtsch Arztebl Int 2023 Jun 23;120(25):434-444. doi: 10.3238/arztebl.m2023.027. PMID: 36794439Free PMC Article
MacLeod M, Papi A, Contoli M, Beghé B, Celli BR, Wedzicha JA, Fabbri LM
Respirology 2021 Jun;26(6):532-551. Epub 2021 Apr 24 doi: 10.1111/resp.14041. PMID: 33893708
Earwood JS, Thompson TD
Am Fam Physician 2015 Feb 15;91(4):243-9. PMID: 25955625

Curated

UK NICE Guideline NG202, Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s, 2021

Recent clinical studies

Etiology

Ruvuna L, Sood A
Clin Chest Med 2020 Sep;41(3):315-327. doi: 10.1016/j.ccm.2020.05.002. PMID: 32800187
Duffy SP, Criner GJ
Med Clin North Am 2019 May;103(3):453-461. Epub 2019 Mar 14 doi: 10.1016/j.mcna.2018.12.005. PMID: 30955513
Poh TY, Mac Aogáin M, Chan AK, Yii AC, Yong VF, Tiew PY, Koh MS, Chotirmall SH
Expert Rev Respir Med 2017 Apr;11(4):285-298. Epub 2017 Mar 24 doi: 10.1080/17476348.2017.1305895. PMID: 28282995
Hattab Y, Alhassan S, Balaan M, Lega M, Singh AC
Crit Care Nurs Q 2016 Apr-Jun;39(2):124-30. doi: 10.1097/CNQ.0000000000000105. PMID: 26919673
Fricker M, Deane A, Hansbro PM
Expert Opin Drug Discov 2014 Jun;9(6):629-45. Epub 2014 Apr 23 doi: 10.1517/17460441.2014.909805. PMID: 24754714

Diagnosis

Labaki WW, Rosenberg SR
Ann Intern Med 2020 Aug 4;173(3):ITC17-ITC32. doi: 10.7326/AITC202008040. PMID: 32745458
Riley CM, Sciurba FC
JAMA 2019 Feb 26;321(8):786-797. doi: 10.1001/jama.2019.0131. PMID: 30806700
Lareau SC, Fahy B, Meek P, Wang A
Am J Respir Crit Care Med 2019 Jan 1;199(1):P1-P2. doi: 10.1164/rccm.1991P1. PMID: 30592446
Segal LN, Martinez FJ
J Allergy Clin Immunol 2018 Jun;141(6):1961-1971. doi: 10.1016/j.jaci.2018.02.035. PMID: 29884286Free PMC Article
Hattab Y, Alhassan S, Balaan M, Lega M, Singh AC
Crit Care Nurs Q 2016 Apr-Jun;39(2):124-30. doi: 10.1097/CNQ.0000000000000105. PMID: 26919673

Therapy

Zhang H, Hu D, Xu Y, Wu L, Lou L
Ann Med 2022 Dec;54(1):262-273. doi: 10.1080/07853890.2021.1999494. PMID: 35037535Free PMC Article
Martinez FJ, Agusti A, Celli BR, Han MK, Allinson JP, Bhatt SP, Calverley P, Chotirmall SH, Chowdhury B, Darken P, Da Silva CA, Donaldson G, Dorinsky P, Dransfield M, Faner R, Halpin DM, Jones P, Krishnan JA, Locantore N, Martinez FD, Mullerova H, Price D, Rabe KF, Reisner C, Singh D, Vestbo J, Vogelmeier CF, Wise RA, Tal-Singer R, Wedzicha JA
Am J Respir Crit Care Med 2022 Feb 1;205(3):275-287. doi: 10.1164/rccm.202107-1663SO. PMID: 34672872Free PMC Article
Vollenweider DJ, Frei A, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA
Cochrane Database Syst Rev 2018 Oct 29;10(10):CD010257. doi: 10.1002/14651858.CD010257.pub2. PMID: 30371937Free PMC Article
Chalmers JD, Chotirmall SH
Lancet Respir Med 2018 Sep;6(9):715-726. Epub 2018 Feb 23 doi: 10.1016/S2213-2600(18)30053-5. PMID: 29478908
Holland AE, Hill CJ, Jones AY, McDonald CF
Cochrane Database Syst Rev 2012 Oct 17;10:CD008250. doi: 10.1002/14651858.CD008250.pub2. PMID: 23076942

Prognosis

Xu S, Ye Z, Ma J, Yuan T
Eur J Clin Invest 2021 Jan;51(1):e13402. Epub 2020 Oct 8 doi: 10.1111/eci.13402. PMID: 32916000
Dugravot A, Fayosse A, Dumurgier J, Bouillon K, Rayana TB, Schnitzler A, Kivimaki M, Sabia S, Singh-Manoux A
Lancet Public Health 2020 Jan;5(1):e42-e50. Epub 2019 Dec 16 doi: 10.1016/S2468-2667(19)30226-9. PMID: 31837974Free PMC Article
Celis-Morales CA, Welsh P, Lyall DM, Steell L, Petermann F, Anderson J, Iliodromiti S, Sillars A, Graham N, Mackay DF, Pell JP, Gill JMR, Sattar N, Gray SR
BMJ 2018 May 8;361:k1651. doi: 10.1136/bmj.k1651. PMID: 29739772Free PMC Article
GBD 2015 Chronic Respiratory Disease Collaborators
Lancet Respir Med 2017 Sep;5(9):691-706. Epub 2017 Aug 16 doi: 10.1016/S2213-2600(17)30293-X. PMID: 28822787Free PMC Article
Suissa S, Dell'Aniello S, Ernst P
Thorax 2012 Nov;67(11):957-63. Epub 2012 Jun 8 doi: 10.1136/thoraxjnl-2011-201518. PMID: 22684094Free PMC Article

Clinical prediction guides

Fazleen A, Wilkinson T
Ther Adv Respir Dis 2020 Jan-Dec;14:1753466620942128. doi: 10.1177/1753466620942128. PMID: 32664818Free PMC Article
Adibi A, Sin DD, Safari A, Johnson KM, Aaron SD, FitzGerald JM, Sadatsafavi M
Lancet Respir Med 2020 Oct;8(10):1013-1021. Epub 2020 Mar 13 doi: 10.1016/S2213-2600(19)30397-2. PMID: 32178776
Bos LD, Sterk PJ, Fowler SJ
J Allergy Clin Immunol 2016 Oct;138(4):970-976. Epub 2016 Aug 31 doi: 10.1016/j.jaci.2016.08.004. PMID: 27590400
Gloeckl R, Marinov B, Pitta F
Eur Respir Rev 2013 Jun 1;22(128):178-86. doi: 10.1183/09059180.00000513. PMID: 23728873Free PMC Article
Hegewald MJ
Clin Rev Allergy Immunol 2009 Dec;37(3):159-66. Epub 2009 Mar 31 doi: 10.1007/s12016-009-8125-2. PMID: 19330553

Recent systematic reviews

Aranburu-Imatz A, López-Carrasco JC, Moreno-Luque A, Jiménez-Pastor JM, Valverde-León MDR, Rodríguez-Cortés FJ, Arévalo-Buitrago P, López-Soto PJ, Morales-Cané I
Int J Environ Res Public Health 2022 Jul 26;19(15) doi: 10.3390/ijerph19159101. PMID: 35897469Free PMC Article
Li Y, Gao H, Zhao L, Wang J
Clin Respir J 2022 Jul;16(7):487-496. Epub 2022 Jun 10 doi: 10.1111/crj.13514. PMID: 35688435Free PMC Article
Vázquez-Gandullo E, Hidalgo-Molina A, Montoro-Ballesteros F, Morales-González M, Muñoz-Ramírez I, Arnedillo-Muñoz A
Int J Environ Res Public Health 2022 May 3;19(9) doi: 10.3390/ijerph19095564. PMID: 35564959Free PMC Article
Keogh E, Mark Williams E
Respir Med 2021 Jan;176:106248. Epub 2020 Nov 21 doi: 10.1016/j.rmed.2020.106248. PMID: 33253970
Varmaghani M, Dehghani M, Heidari E, Sharifi F, Moghaddam SS, Farzadfar F
East Mediterr Health J 2019 Mar 19;25(1):47-57. doi: 10.26719/emhj.18.014. PMID: 30919925

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NICE, 2021
      UK NICE Guideline NG202, Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s, 2021

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...